Literature DB >> 32569495

Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection.

Mahmut Atum1, Ali Altan Ertan Boz1, Burçin Çakır1, Oğuz Karabay2, Mehmet Köroğlu3, Aziz Öğütlü2, Gürsoy Alagöz1.   

Abstract

PURPOSE: The study objective was to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in conjunctival swabs from patients with confirmed SARS-CoV-2 infection.
METHODS: Forty patients who tested positive by real-time reverse transcription (rRT)-polymerase chain reaction (PCR) of nasopharyngeal and oropharyngeal swabs were enrolled. Conjunctival swabbing was used to collect the tear and conjunctival secretions of patients.
RESULTS: Conjunctival swab rRT-PCR was positive for three patients and negative for 37 patients. Ten of the patients (25%) were diagnosed with conjunctivitis during the ophthalmic examination. Of these patients, one was found positive by conjunctival swab rRT-PCR, and nine were found negative. The difference between patients who tested positive or negative using conjunctival swab rRT-PCR was without statistical significance in terms of the presence of conjunctivitis (p = .720).
CONCLUSION: The rate of positivity from conjunctival swab rRT-PCR was 7.5% in patients with confirmed SARS-CoV-2 infection.

Entities:  

Keywords:  SARS-CoV-2; conjunctival swab; ocular disease

Mesh:

Substances:

Year:  2020        PMID: 32569495     DOI: 10.1080/09273948.2020.1775261

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  19 in total

Review 1.  COVID-19 and the eye: alternative facts The 2022 Bowman Club, David L. Easty lecture.

Authors:  Lawson Ung; James Chodosh
Journal:  BMJ Open Ophthalmol       Date:  2022-05

Review 2.  An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards.

Authors:  Amani E Badawi; Sara S Elsheikh; Sarah Zaher Addeen; Mostafa A Soliman; Rami Abd-Rabu; Walid Shaban Abdella; Elham A Gad
Journal:  J Curr Ophthalmol       Date:  2020-12-12

3.  COVID-19 and conjunctivitis: a meta-analysis.

Authors:  Mashael Al-Namaeh
Journal:  Ther Adv Ophthalmol       Date:  2021-03-25

Review 4.  Evidence of SARS-CoV-2 Transmission Through the Ocular Route.

Authors:  Jing-Yu Qu; Hua-Tao Xie; Ming-Chang Zhang
Journal:  Clin Ophthalmol       Date:  2021-02-18

Review 5.  Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.

Authors:  Yu-Yen Chen; Yung-Feng Yen; Li-Ying Huang; Pesus Chou
Journal:  J Ophthalmol       Date:  2021-06-19       Impact factor: 1.909

6.  Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses.

Authors:  Sneha Singh; Onkar B Sawant; Shahzad I Mian; Ashok Kumar
Journal:  Biomolecules       Date:  2021-05-18

Review 7.  Update and Recommendations for Ocular Manifestations of COVID-19 in Adults and Children: A Narrative Review.

Authors:  Veena Danthuluri; Maria B Grant
Journal:  Ophthalmol Ther       Date:  2020-10-15

Review 8.  Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2.

Authors:  G Kampf; Y Brüggemann; H E J Kaba; J Steinmann; S Pfaender; S Scheithauer; E Steinmann
Journal:  J Hosp Infect       Date:  2020-09-18       Impact factor: 3.926

9.  Ocular transmission and manifestation for coronavirus disease: a systematic review.

Authors:  Ahmed Almazroa; Suhailah Alamri; Balsam Alabdulkader; Hanan Alkozi; Altaf Khan; Walead Alghamdi
Journal:  Int Health       Date:  2022-03-02       Impact factor: 2.473

10.  Detection of coronavirus-2 by real-time reverse transcription polymerase chain reaction in conjunctival swabs from patients with severe form of Coronavirus disease 2019 in São Paulo, Brazil.

Authors:  Mariana Akemi Matsura Misawa; Tatiana Tanaka; Tomás Minelli; Pedro Gomes Oliveira Braga; Juliana Mika Kato; Michele Soares Gomes Gouvêa; João Renato Rebello Pinho; Joyce Hisae Yamamoto
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.